MedTrace Logo

Neuropsychological Sequelae and Long COVID-19 Fatigue

NCT05323318 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-03-14

No results posted yet for this study

Summary

An association of fatigue with post-viral neuropsychological disturbs has been reported. Among patients hospitalized with COVID-19 there is an increased incidence of anxiety and depression symptoms. In addition, a quarter of patients experience at least mild symptoms of acute post traumatic stress disorder. (Mazza, M. G. et al 2020). The prevalence of chronic fatigue syndrome had a correlation with post-traumatic stress disorder (PTSD) in a study conducted after the outbreak of the COVID-19 in Iran (Silmani et al, 2021), that showed 5.8% of subjects suffering from PTSD after 6 months of SARS-CoV-2 infection onset.

In this Study we propose to use a tool to quantify the degree of physical and psychological fatigue in post-COVID-19 patients, and assess the correlation of fatigue with the neuropsychiatric sequelae in hospitalized and non hospitalized patients.

Conditions

  • Anxiety Depression
  • Post Traumatic Stress Disorder
  • Mental Fatigue
  • COVID-19
  • Fatigue Syndrome, Chronic

Interventions

OTHER

Neuropsychological Sequelae

Neuropsychological Sequelae after SARS-CoV-2 symtomatic infection

Sponsors & Collaborators

  • Universidade do Algarve

    collaborator OTHER

  • Universidade do Porto

    collaborator OTHER

  • Centro Hospitalar Universitario do Algarve

    lead OTHER

Principal Investigators

  • Ligia Pires, MD · Centro Hospitalar Universitario do Algarve

  • Joana Berger, PHD · Universitat Bern

  • Ligia Pires, MD · Centro Hospitalar Universitario do Algarve

  • Marta Drummond, PHD · Universidade do Porto

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-03-30
Completion
2023-04-30

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05323318 on ClinicalTrials.gov